Our data revealed that the mRNA expression of survivin in HPV− HNSCC cells was downregulated by palbociclib, an inhibitor of CDK4/6, indicating that the CDK4/6-Rb pathway regulates survivin gene expression. Here, CDK4 is linked to head and neck squamous cell carcinoma.